OPRX Quote, Financials, Valuation and Earnings

AMN Healthcare Services, Inc. has a net margin of 2.99% compared to OptimizeRx Corp.'s net margin of 4.62%. OptimizeRx Corp.'s return on equity of 0.03% beat AMN Healthcare Services, Inc.'s return on equity of -38.65%.

OptimizeRx Corp. has a consensus price target of $24.33, signalling upside risk potential of 90.7%. On the other hand AMN Healthcare Services, Inc. has an analysts' consensus of $20.43 which suggests that it could grow by 27.76%. Given that OptimizeRx Corp. has higher upside potential than AMN Healthcare Services, Inc., analysts believe OptimizeRx Corp. is more attractive than AMN Healthcare Services, Inc..

OptimizeRx Corp. has a beta of 1.099, which suggesting that the stock is 9.906% more volatile than S&P 500. In comparison AMN Healthcare Services, Inc. has a beta of 0.213, suggesting its less volatile than the S&P 500 by 78.742%.

OptimizeRx Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AMN Healthcare Services, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OptimizeRx Corp. pays -- of its earnings as a dividend. AMN Healthcare Services, Inc. pays out -- of its earnings as a dividend.

OptimizeRx Corp. quarterly revenues are $26.1M, which are smaller than AMN Healthcare Services, Inc. quarterly revenues of $634.5M. OptimizeRx Corp.'s net income of $779K is lower than AMN Healthcare Services, Inc.'s net income of $29.3M. Notably, OptimizeRx Corp.'s price-to-earnings ratio is -- while AMN Healthcare Services, Inc.'s PE ratio is 18.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OptimizeRx Corp. is 2.20x versus 0.23x for AMN Healthcare Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Health Catalyst, Inc. has a net margin of 2.99% compared to OptimizeRx Corp.'s net margin of -29.13%. OptimizeRx Corp.'s return on equity of 0.03% beat Health Catalyst, Inc.'s return on equity of -30.29%.

OptimizeRx Corp. has a consensus price target of $24.33, signalling upside risk potential of 90.7%. On the other hand Health Catalyst, Inc. has an analysts' consensus of $3.94 which suggests that it could grow by 65.73%. Given that OptimizeRx Corp. has higher upside potential than Health Catalyst, Inc., analysts believe OptimizeRx Corp. is more attractive than Health Catalyst, Inc..

OptimizeRx Corp. has a beta of 1.099, which suggesting that the stock is 9.906% more volatile than S&P 500. In comparison Health Catalyst, Inc. has a beta of 1.723, suggesting its more volatile than the S&P 500 by 72.331%.

OptimizeRx Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Health Catalyst, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OptimizeRx Corp. pays -- of its earnings as a dividend. Health Catalyst, Inc. pays out -- of its earnings as a dividend.

OptimizeRx Corp. quarterly revenues are $26.1M, which are smaller than Health Catalyst, Inc. quarterly revenues of $76.3M. OptimizeRx Corp.'s net income of $779K is higher than Health Catalyst, Inc.'s net income of -$22.2M. Notably, OptimizeRx Corp.'s price-to-earnings ratio is -- while Health Catalyst, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OptimizeRx Corp. is 2.20x versus 0.51x for Health Catalyst, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Humana, Inc. has a net margin of 2.99% compared to OptimizeRx Corp.'s net margin of 0.59%. OptimizeRx Corp.'s return on equity of 0.03% beat Humana, Inc.'s return on equity of 7.3%.

OptimizeRx Corp. has a consensus price target of $24.33, signalling upside risk potential of 90.7%. On the other hand Humana, Inc. has an analysts' consensus of $287.83 which suggests that it could grow by 11.03%. Given that OptimizeRx Corp. has higher upside potential than Humana, Inc., analysts believe OptimizeRx Corp. is more attractive than Humana, Inc..

OptimizeRx Corp. has a beta of 1.099, which suggesting that the stock is 9.906% more volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.462, suggesting its less volatile than the S&P 500 by 53.84%.

OptimizeRx Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana, Inc. offers a yield of 1.37% to investors and pays a quarterly dividend of $0.89 per share. OptimizeRx Corp. pays -- of its earnings as a dividend. Humana, Inc. pays out 35.45% of its earnings as a dividend. Humana, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

OptimizeRx Corp. quarterly revenues are $26.1M, which are smaller than Humana, Inc. quarterly revenues of $32.6B. OptimizeRx Corp.'s net income of $779K is lower than Humana, Inc.'s net income of $194M. Notably, OptimizeRx Corp.'s price-to-earnings ratio is -- while Humana, Inc.'s PE ratio is 24.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OptimizeRx Corp. is 2.20x versus 0.25x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Option Care Health, Inc. has a net margin of 2.99% compared to OptimizeRx Corp.'s net margin of 3.61%. OptimizeRx Corp.'s return on equity of 0.03% beat Option Care Health, Inc.'s return on equity of 15.16%.

OptimizeRx Corp. has a consensus price target of $24.33, signalling upside risk potential of 90.7%. On the other hand Option Care Health, Inc. has an analysts' consensus of $36.45 which suggests that it could grow by 12.69%. Given that OptimizeRx Corp. has higher upside potential than Option Care Health, Inc., analysts believe OptimizeRx Corp. is more attractive than Option Care Health, Inc..

OptimizeRx Corp. has a beta of 1.099, which suggesting that the stock is 9.906% more volatile than S&P 500. In comparison Option Care Health, Inc. has a beta of 0.796, suggesting its less volatile than the S&P 500 by 20.434%.

OptimizeRx Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OptimizeRx Corp. pays -- of its earnings as a dividend. Option Care Health, Inc. pays out -- of its earnings as a dividend.

OptimizeRx Corp. quarterly revenues are $26.1M, which are smaller than Option Care Health, Inc. quarterly revenues of $1.4B. OptimizeRx Corp.'s net income of $779K is lower than Option Care Health, Inc.'s net income of $51.8M. Notably, OptimizeRx Corp.'s price-to-earnings ratio is -- while Option Care Health, Inc.'s PE ratio is 25.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OptimizeRx Corp. is 2.20x versus 0.97x for Option Care Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.